Login / Signup

Factors Associated With Receiving Longer Than Recommended Therapy Among Culture-Negative Pulmonary Tuberculosis Patients.

Clarisse A TsangNeha N PatelJason E StoutRobyn FernandoRobert PrattNeela D Goswami
Published in: Open forum infectious diseases (2022)
Most patients potentially eligible for 4-month therapy were treated with standard 6-month courses. Beyond clinical eligibility criteria, other patient- and program-related factors might be more critical determinants of treatment duration.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • pulmonary tuberculosis
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • mycobacterium tuberculosis
  • bone marrow
  • patient reported